In addition, the Chemo + PD-L1 regimen also showed a higher risk of severe leukopenia compared with the Chemo + CTLA-4 regimen (RR, 3.02; 95%CI, 1.28–7.99). The gene discussed is CTLA4; the disease is Decreased total leukocyte count.